The Institute of Cancer Research

Myeloma cells
#Genetics #Myeloma #Oncology #Personalised medicine #The Institute of Cancer Research

Personalised treatment needed for high-risk myeloma, say scientists

Offering genetic testing to patients with myeloma would help doctors spot those with the most aggressive forms of the disease so that their cancer can be targeted more effectively, say scientists.  With effective treatment, more than half of myeloma patients will survive their disease for five years… Read More

#Cancer Research #Editor's Choice #News

The extracellular matrix
#Barts Institute #Oncology #The Institute of Cancer Research #Tumour microenvironment (TME)

Cancer breakthrough could stop tumours before they metastasise

Scientists have discovered a new way to predict which tumours will become aggressive before they metastasise and spread around the body.  The research, published in Nature Communications, reveals how cancer cells are altered by their surroundings, enabling them to change their… Read More

#Cancer Research #News #Trending News

The tumour microenvironment
#Chemotherapy-resistance #Drug resistance #Oncology #The Institute of Cancer Research #Tumour microenvironment (TME)

Study reveals role of the secretome in cancer drug resistance

A new study has shown that non-cancerous cells positioned close to tumours can affect how cancer responds to treatment.   The researchers say factoring in the effects of these cells could improve drug development and provide new insights into the most effective use of existing cancer medications. … Read More

#Cancer Research #Editor's Choice #News

#Artificial intelligence (AI) #Oncology #Sentinal4D #Spinout #Start-ups #The Institute of Cancer Research

Precision oncology spinout hopes to expedite drug discovery

Sentinal4D, a spinout company from The Institute of Cancer Research (ICR), London, has been announced to the public after closing its first round of funding.  The new company aims to accelerate drug discovery and development to target drugs to patients, using patented artificial intelligence-driven methods for personalised therapeutics, with a… Read More

#Business & Investment #News #Start-up Zone

Genomics
#Gene sequencing #Genetics / genomics #Oncology #The Institute of Cancer Research

Whole-genome sequencing reveals new potential cancer-driving genes

Researchers have identified 330 potential cancer-driving genes, 74 of which are newly associated with cancer. The findings highlight the potential to develop new, more targeted treatment options and provide hope that existing cancer treatments, such as PARP inhibitors, could be extended to thousands more patients. Read More

#Cancer Research #Editor's Choice #News

Leukaemia
#Acute Myeloid Leukaemia #Blood cancer #Oncology #The Institute of Cancer Research

New target for acute myeloid leukaemia discovered

Researchers have identified a key weakness in acute myeloid leukaemia (AML), offering a promising new strategy to delay the progression of this aggressive blood cancer. The discovery focuses on disrupting the function of the nucleosome-remodelling factor (NURF) complex, which cancer cells, including leukaemia cells, rely on… Read More

#Cancer Research #Editor's Choice #News

Human brain
#Brain cancer #Dana-Farber Cancer Institute #Drug repurposing #Oncology #The Institute of Cancer Research

Breast cancer drug could treat rare childhood brain tumours

Ribociclib – a drug already used to treat breast cancer – may help slow the growth of diffuse hemispheric glioma (DHG), new research has found. A team of scientists from The Institute of Cancer Research, London and the Dana-Farber Cancer Institute, Boston, USA, have uncovered clues… Read More

#Cancer Research #Editor's Choice #News

Genetics
#Colorectal cancer #Genetics / genomics #The Institute of Cancer Research #The University of Manchester #University of Leeds #University of Oxford

Genetic causes of colorectal cancer revealed in new study

A new study has provided the most comprehensive analysis to date of the genetic makeup of colorectal cancer (CRC), providing unique understanding of its response to treatment. The research was led by UK universities, including the University of Oxford, The Institute of Cancer Research, London, the… Read More

#Cancer Research #News

Cancer cell
#Breast Cancer Now #Oncology #The Institute of Cancer Research #Treatment resistance

Science reveals how cancer cells outsmart normal cells

Scientists have discovered that some cancer cells pretend to be ‘super fit’ to fool normal healthy cells into giving them their nutrients, allowing them to expand and spread around the body. A team from The Institute of Cancer Research (ICR), London, found that ‘cheating’ cancer cells… Read More

#Cancer Research #News #Trending News

Melanoma or skin cancer
#3D imaging #Cancer drug targets #Drug targets #Oncology #Skin cancer #The Institute of Cancer Research

Discovery reveals two potential drug targets against skin cancer

Scientists have discovered how skin cancer cells shapeshift based on their environment – enabling them to spread through the body and cause a metastatic cancer. The discovery of two genes responsible for sensing the environment and adapting cell shape could offer potential new drug targets to… Read More

#Cancer Research #Editor's Choice #News

Cancer cells
#Breast cancer #Drug targets #Epigenetics #Oncology #The Institute of Cancer Research

Research uncovers how to target dormant breast cancer cells

Scientists have discovered how breast cancer cells can ‘hibernate’ to avoid treatment and ‘wake up’ years later – causing a relapse that is more difficult to treat. Their research, published in the journal Cancer Discovery, reveals the role of epigenetics in controlling how cancer cells can… Read More

#Cancer Research #News

MRI showing glioblastoma
#Brain cancer #Oncology #Phase I trial #The Institute of Cancer Research #The Royal Marsden NHS Foundation Trust

‘Olive oil’ drug shows early promise in brain cancer

A drug derived from oleic acid – which naturally occurs in animal and vegetable fats such as olive oil – has shown promise for patients with brain cancer, following a study led by The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK. Results… Read More

#Cancer Research #News

Breast cancer cell
#Breast cancer #Cancer research #Oncology #The Institute of Cancer Research

Discovery lights the way for new secondary breast cancer drugs

Using a novel approach, researchers from The Institute of Cancer Research, London have uncovered details of secondary breast cancer in the brain and spinal cord that may help with developing effective treatments. The study revealed for the first time that breast cancer leptomeningeal metastasis (BCLM) cells… Read More

#Cancer Research #News

Prostate cancer cells
#Drug resistance #Oncology #Prostate cancer #The Institute of Cancer Research #The Institute of Oncology Research #The Royal Marsden NHS Foundation Trust

Researchers reverse prostate cancer drug resistance

Prostate cancer’s resistance to treatment can be reversed in some patients by stopping hijacked white blood cells from being ‘pulled into’ tumours, according to new research published in Nature. In an early clinical trial, researchers showed that blocking the messages cancer uses to hijack white blood… Read More

#Cancer Research #News #Trending News

Research laboratory
#Cancer research #Collaboration #Merck #Oncology #The Institute of Cancer Research

ICR and Merck renew cancer drug discovery alliance

Merck and The Institute of Cancer Research (ICR), London, UK, have renewed their strategic alliance in the discovery and development of new cancer drugs. Scientists in the Centre for Cancer Drug Discovery at the ICR will work with researchers at Merck to discover and develop new… Read More

#Cancer Research #News